Neogen Corporation (NASDAQ:NEOG - Get Free Report)'s stock price hit a new 52-week high on Tuesday . The stock traded as high as $13.72 and last traded at $13.61, with a volume of 4398460 shares changing hands. The stock had previously closed at $13.00.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on the company. Piper Sandler raised Neogen from a "neutral" rating to an "overweight" rating and lifted their target price for the stock from $13.00 to $14.00 in a research report on Wednesday, August 26th. Weiss Ratings upgraded shares of Neogen from a "sell (e+)" rating to a "sell (d-)" rating in a research report on Friday, August 7th. Finally, Wall Street Zen lowered Neogen from a "strong-buy" rating to a "buy" rating in a research note on Sunday. Three research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and an average target price of $12.00.
Read Our Latest Analysis on NEOG
Neogen Stock Performance
The stock's 50-day moving average is $11.36 and its 200 day moving average is $9.98. The firm has a market cap of $2.97 billion, a P/E ratio of -453.67, a PEG ratio of 4.88 and a beta of 1.76. The company has a debt-to-equity ratio of 0.38, a quick ratio of 2.91 and a current ratio of 3.82.
Neogen (NASDAQ:NEOG - Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The company reported $0.09 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.03. The business had revenue of $225.30 million for the quarter, compared to analysts' expectations of $212.35 million. Neogen had a positive return on equity of 2.78% and a negative net margin of 0.91%.Neogen's revenue for the quarter was down .1% on a year-over-year basis. During the same quarter in the previous year, the business posted ($2.82) EPS. On average, research analysts predict that Neogen Corporation will post 0.27 earnings per share for the current year.
Hedge Funds Weigh In On Neogen
Large investors have recently bought and sold shares of the company. Nykredit A S acquired a new stake in Neogen in the 2nd quarter valued at $28,000. Public Employees Retirement System of Ohio bought a new position in shares of Neogen during the 2nd quarter worth approximately $34,000. Hantz Financial Services Inc. increased its holdings in shares of Neogen by 816.9% in the fourth quarter. Hantz Financial Services Inc. now owns 7,592 shares of the company's stock valued at $53,000 after purchasing an additional 6,764 shares during the last quarter. Integrated Wealth Concepts LLC bought a new position in Neogen in the 2nd quarter valued at about $73,000. Finally, Alpine Global Management LLC bought a new position in shares of Neogen during the fourth quarter worth approximately $89,000. Institutional investors and hedge funds own 96.73% of the company's stock.
Neogen Company Profile
(
Get Free Report)
Neogen Corporation develops and markets products and services designed to protect food, animals and people. The company's offerings help customers detect, prevent and manage biological, chemical and physical hazards across the food production, agricultural and animal care industries.
Its food safety portfolio includes test kits and related technologies for detecting pathogens, allergens, mycotoxins, spoilage organisms, veterinary drug residues and other contaminants. Neogen also provides sanitation and hygiene products, diagnostic tools, laboratory services, software and training for food manufacturers, processors, retailers and other organizations involved in the food supply chain.
Neogen's animal safety business serves livestock, poultry, companion animal and veterinary markets.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Neogen, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Neogen wasn't on the list.
While Neogen currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.